This inventor holds 1 USPTO granted patent. Top assignee: Retroscreen Ltd.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Lynne Bountiff: Innovator in AIDS Therapy
Introduction
Lynne Bountiff is a notable inventor based in Aylebury, GB. She has made significant contributions to the field of medical science, particularly in the area of HIV-induced AIDS therapy and vaccine development. Her innovative work has the potential to change the landscape of treatment for individuals affected by this condition.
Latest Patents
Lynne Bountiff holds a patent for her invention related to AIDS therapy and vaccine. The patent provides therapy and prophylaxis against HIV-induced AIDS. It also includes methods for determining an individual's susceptibility to HIV-induced AIDS. The invention is based on the discovery that AIDS results from gp120 of HIV mimicking the antigen-presenting component of the immune system. This spurious activation of certain CD4+ T cells in susceptible individuals leads to a condition similar to graft versus host disease. The condition can be treated by eliminating the responsible T cells.
Career Highlights
Throughout her career, Lynne has demonstrated a commitment to advancing medical research and innovation. She has worked diligently to develop therapies that address critical health issues. Her work at Retroscreen Ltd. has positioned her as a leader in her field, contributing to groundbreaking advancements in AIDS treatment.
Collaborations
Lynne Bountiff has collaborated with esteemed colleagues such as John Anthony Habeshaw and Angus George Dalgleish. These partnerships have fostered an environment of innovation and have led to significant advancements in their shared field of research.
Conclusion
Lynne Bountiff's contributions to AIDS therapy and vaccine development highlight her role as a pioneering inventor. Her work not only addresses a pressing health issue but also showcases the importance of innovation in medical science.